Overview

DEgenerative ROtator Cuff Disease and Botulinum TOXin: a Randomized Trial

Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess the effectiveness of botulinum toxin in persistent shoulder pain due to degenerative rotator cuff disease.
Phase:
Phase 2
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborator:
Merz Pharmaceuticals GmbH
Treatments:
incobotulinumtoxinA